New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 4, 2012
10:00 EDTLVS, TDW, HOS, CLB, RY, MDVN, FLS, GLW, ALE, THS, SBUX, LGP, DNKN, CBOU, ALXA, THI, TD, NCS, IMPV, DSW, BNSOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Alexza Pharmaceuticals (ALXA) initiated with a Buy at Roth Capital... Allete (ALE) initiated with a Buy at KeyBanc... Bank of Nova Scotia (BNS) initiated with a Neutral at Citigroup... Caribou Coffee (CBOU) initiated with a Buy at Longbow... Corning (GLW) initiated with an Outperform at Bernstein... DSW Inc. (DSW) initiated with an Outperform at William Blair... Dunkin' Brands (DNKN) initiated with a Buy at Longbow... Flowserve (FLS) initiated with a Buy at KeyBanc... Imperva (IMPV) initiated with an Outperform at Oppenheimer... Lehigh Gas (LGP) initiated with a Buy at Janney Capital... Lehigh Gas (LGP) initiated with an Outperform at RW Baird... Medivation (MDVN) initiated with an Equal Weight at Barclays... NCI Building Systems (NCS) initiated with an Outperform at FBR Capital... Royal Bank of Canada (RY) initiated with a Buy at Citigroup... Starbucks (SBUX) initiated with a Buy at Longbow... Toronto-Dominion (TD) initiated with a Buy at Citigroup... TreeHouse Foods (THS) initiated with a Buy at Longbow... Tim Hortons (THI) initiated with a Buy at Longbow... Core Laboratories (CLB) initiated with a Buy at Global Hunter... Las Vegas Sands (LVS) initiated with a Buy at Craig-Hallum... Hornbeck Offshore (HOS) coverage resumed with a Neutral at Goldman... Tidewater (TDW) coverage resumed with a Neutral at Goldman.
News For ALXA;ALE;BNS;CBOU;GLW;DSW;DNKN;FLS;IMPV;LGP;MDVN;NCS;SBUX;RY;TD;THS;CLB;THI;LVS;HOS;TDW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
August 26, 2015
08:08 EDTDSWDSW price target lowered to $37 from $46 at Canaccord
Subscribe for More Information
07:50 EDTTHSTreeHouse upgraded to Overweight from Equal Weight at Stephens
Subscribe for More Information
06:14 EDTRYRoyal Bank of Canada reports Q3 EPS excluding items C$1.66, cash EPS C$1.68
Subscribe for More Information
August 25, 2015
16:43 EDTDSWOn The Fly: Top stock stories for Tuesday
Subscribe for More Information
09:13 EDTDSWOn The Fly: Pre-market Movers
Subscribe for More Information
07:36 EDTSBUXStarbucks CEO tells workers to be nice to stock-stressed customers, Fusion says
Subscribe for More Information
07:03 EDTDSWDSW backs FY15 EPS $1.80-$1.90, consensus $1.91
Subscribe for More Information
07:02 EDTDSWDSW reports Q2 EPS 42c, consensus 42c
Subscribe for More Information
August 24, 2015
15:09 EDTDSWNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Best Buy (BBY), consensus 34c... Toll Brothers (TOL), consensus 49c... Valspar (VAL), consensus $1.26... DSW (DSW), consensus 42c... Children's Place (PLCE), consensus (33c).
14:21 EDTIMPVJMP Securities says pullback in Palo Alto a buying opportunity
Subscribe for More Information
08:36 EDTIMPVIT security outlook still positive, says Pacific Crest
After attending a conference and analyzing IT security companies' Q2 results, Pacific Crest is more confident that IT security spending trends will continue to be strong. The firm identifies Barracuda (CUDA), Imperva (IMPV) and Palo Alto (PANW) as its favorite names in the space.
07:02 EDTMDVNMedivation to acquire worldwide rights to Talazoparib from BioMarin
Medivation (MDVN) and BioMarin Pharmaceutical (BMRN) have entered into an asset purchase agreement under which Medivation will acquire all worldwide rights to talazoparib, a highly-potent, orally-available poly ADP ribose polymerase inhibitor currently in a Phase 3 study for the treatment of patients with deleterious germline BRCA 1 or BRCA 2 mutations and locally advanced and/or metastatic breast cancer. Under the agreement, Medivation will be responsible for all research, development, regulatory and commercialization activities for all indications on a global basis. Under the terms of the agreement, Medivation will pay BioMarin $410 million upfront, up to an additional $160 million upon the achievement of regulatory and sales-based milestones and mid-single digit royalties for talazoparib. At the closing of the transaction, Medivation will assume all financial obligations associated with the development and commercialization of talazoparib. The closing of the transaction is conditioned on the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. The transaction is anticipated to close in 2015.
August 23, 2015
19:56 EDTTHSTreeHouse in talks to buy ConAgra private label unit for $3B, NY Post says
TreeHouse Foods (THS) chairman and CEO Sam Reed privately told certain investors last week that the company is in talks to buy ConAgra's (CAG) Ralcorp private label food unit for roughly $3B, reports the New York Post, citing a source with inside knowledge. Post Holdings (POST) is also eyeing Ralcorp, sources told the publication. Reference Link
August 21, 2015
16:01 EDTLVSOptions Update; August 21, 2015
Subscribe for More Information
08:40 EDTBNSCanadian Security Traders Association to hold a conference
Subscribe for More Information
07:17 EDTLVSMacau developments negative, says Wells Fargo
Wells Fargo says that its checks on Macau for August indicate that the region's revenues are trending flat to down this month. According to Wells, in August the region's revenues are historically up 4% versus July. The firm adds that comments by Macau casino owner Galaxy suggest that the market has not yet bottomed. Wells believes that the market has not yet stabilized and remains neutral on Macau stocks, although it remains upbeat on their long-term outlook. Publicly traded companies in the Macau gaming space include Las Vegas Sands (LVS), MGM Resorts (MGM), Melco Crown (MPEL) and Wynn Resorts (WYNN).
August 20, 2015
15:56 EDTRYWindstream said to hire RBC to explore sale of data storage business
Subscribe for More Information
09:30 EDTDSWDSW Q2 revenue tracking below consensus, says ITG Research
Subscribe for More Information
08:16 EDTCLBCore Laboratories management to meet with RBC Capital
Subscribe for More Information
August 19, 2015
06:12 EDTDNKN, SBUXStarbucks K-cup momentum is accelerating, says UBS
UBS analyst Keith Siegner says Starbucks (SBUX) is seeing accelerating momentum in the single-serve cup category. The company's K-cup sales increased 36% year-over-year for the four-week period ended August 8, according to Nielsen (NLSN), Siegner tells investors in a research note. Starbucks' K-cup promotion levels ticked up sequentially, but remain well below levels from earlier in the year, the analyst points out. The company's K-Cup portfolio continues to gain share despite increasing price pressure and new market entrants like Dunkin' Brands (DNKN) and McDonald's (MCD), Siegner writes. He keeps a Buy rating on Starbucks with a $63 price target. The stock closed yesterday up 9c to $57.83. Shares of Keurig Green Mountain (GMCR) are down 62% year-to-date in part due to the company's slowing sales in the single-serve cup category.
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use